IP Verse

Paediatric Solutions Comprising A Beta-Blocker - EP2421504

The patent EP2421504 was granted to Pierre Fabre Dermatologie on Aug 10, 2022. The application was originally filed on Apr 12, 2010 under application number EP10717263A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2421504

PIERRE FABRE DERMATOLOGIE
Application Number
EP10717263A
Filing Date
Apr 12, 2010
Status
Patent Maintained As Amended
Jul 8, 2022
Grant Date
Aug 10, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

AECHTERDec 8, 2017TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTDE102006020604
INTERNATIONAL-SEARCH-REPORTGB2264866
INTERNATIONAL-SEARCH-REPORTUS4600708
OPPOSITIONGB2264866
OPPOSITIONUS4600708
OPPOSITIONWO2009050567
OPPOSITIONWO2010122442

Non-Patent Literature (NPL) Citations (14) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- D. WOODS, EXTEMPORANEOUS FORMULATIONS OF ORAL LIQUIDS, A GUIDE-
DESCRIPTION- FRITZ ET AL., "Effect of beta-blockade on symptomatic dexamethasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review", J. PERINATAL, (1998), vol. 18, pages 38 - 44-
DESCRIPTION- KILIAN K., "Hypertension in neonates causes and treatments", J PERINAT NEONATAL NURS, (2003), vol. 17, pages 65 - 74-
DESCRIPTION- TAKAHASHI ET AL., OPHTALMIC RES., (1983), vol. 15, pages 277 - 279-
DESCRIPTION- V. DAS GUPTA, "Stability of Propranolol Hydrochloride Suspension and solution compounded from injection or tablets", AM. J. OF HOSPITAL PHARMACY, (1987), vol. 44, pages 360 - 361-
DESCRIPTION- VILLAIN ET AL., "Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome", EUR HEART J, (2004), vol. 25, pages 1405 - 11-
DESCRIPTION- C. LéAUTé-LABRèZE ET AL., "Propranolol for severe hemangiomas of infancy", N. ENGL. J. CHEM., (2008), vol. 358, no. 24, doi:doi:10.1056/NEJMc0708819, pages 2649 - 51, XP002523408
INTERNATIONAL-SEARCH-REPORT- TAKAHASHI N., MUROTA H., SUTOH I., "Antimicrobial activity of topical beta-adrenergic blocking agents", OPHTALMIC RES., (1983), vol. 15, no. 6, pages 277 - 279, XP008112326 [I] 20,21 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- C.LEAUTE; E. DUMAS DE LA ROQUE; T: HUBICHE; F: BORALEVI; JB THAMBO; A. TAIEB, "propranolol for severe hemangiomas of infancy", N ENG JOURNAL OF MEDECINE, (20080612), vol. 358, no. 24, pages 2649 - 2651, XP002546760 [A] 16 * the whole document *
OPPOSITION- Bonifazi E; Colonna V; Mazzotta F; Balducci G; Laforgia N, "Propranolol in rapidly growing hemangiomas", EUROPEAN JOURNAL OF PEDIATRIC DERMATO,, (20080700), vol. 18, no. 3, pages 185 - 192, XP008105082-
OPPOSITION- Bonifazi E et al, "Propranolol in rapidly growing hemangiomas", EUROPEAN JOURNAL OF PEDIATRIC DERMATO,, (20080700), vol. 18, no. 3, pages 185 - 192-
OPPOSITION- KRUSZEWSKA et al., "Examination of Antimicrobial Activity of Selected Non- Antibiotic Drugs", ACTA POLONIAE PHARMACEUTICA, (20041200), ISSN 0001-6837, pages 18 - 21, XP055445311-
OPPOSITION- L. M. DAWSON et al., "Guidelines for Compounding Oral Medications for Pediatric Patients", Journal of Pharmacy Technology, (19910900), vol. 7, pages 168 - 175, XP055445290-
OPPOSITION- PAWAR et al., "Issues in the Formulation of Drugs for Oral Use in Children", Pediatr. Drugs, (20020000), vol. 4, no. 6, pages 371 - 379, XP055445302-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents